Jones Financial Companies Lllp Bei Gene, Ltd. Transaction History
Jones Financial Companies Lllp
- $105 Billion
- Q4 2024
A detailed history of Jones Financial Companies Lllp transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Jones Financial Companies Lllp holds 10 shares of BGNE stock, worth $2,267. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10
Previous 5
100.0%
Holding current value
$2,267
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BGNE
# of Institutions
249Shares Held
45MCall Options Held
265KPut Options Held
87.3K-
Baker Bros. Advisors LP New York, NY10.6MShares$2.4 Billion25.41% of portfolio
-
Capital International Investors Los Angeles, CA6.11MShares$1.39 Billion0.22% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$1.17 Billion26.65% of portfolio
-
Primecap Management CO Pasadena, CA5.1MShares$1.16 Billion0.74% of portfolio
-
Baillie Gifford & CO3.67MShares$832 Million0.54% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $23.5B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...